Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

Miriam Kolko; Gus Gazzard; Christophe Baudouin; Sofie Beier; Françoise Brignole-Baudouin; Barbara Cvenkel; Fredrik Fineide; Anne Hedengran; Anton Hommer; Erik Jespersen; Elisabeth M. Messmer; Rachna Murthy; Amy Gallant Sullivan; Andrew J. Tatham; Tor Paaske Utheim; Marijke Vittrup; David A. Sullivan

doi:10.1016/j.jtos.2023.05.012

Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

Miriam Kolko, Gus Gazzard, Christophe Baudouin, Sofie Beier, Françoise Brignole-Baudouin, Barbara Cvenkel, Fredrik Fineide, Anne Hedengran, Anton Hommer, Erik Jespersen, Elisabeth M. Messmer, Rachna Murthy, Amy Gallant Sullivan, Andrew J. Tatham, Tor Paaske Utheim, Marijke Vittrup, David A. Sullivan^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

14 Citations (Scopus)

8 Downloads (Pure)

Original language	English
Journal	Ocular Surface
Volume	29
Pages (from-to)	456-468
ISSN	1542-0124
DOIs	https://doi.org/10.1016/j.jtos.2023.05.012
Publication status	Published - 2023

Bibliographical note

Funding Information:
Tor Paaske Utheim - Co-owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch + Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, Laboratoire Théa. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire Pharmaceuticals.

Funding Information:
TFOS expresses its appreciation to Julie Karimi (www.jaka.it), Sabrina Zappia (www.citynetonline.it) and Jeremy Chung Bo Chiang (Sydney, Australia) for their outstanding assistance. TFOS also thanks the following industry partners who supported this TFOS Experts' Meeting with unrestricted donations: Santen, Bausch + Lomb, Dompé, Glaukos, URSAPHARM, Laboratoires Théa and VISUfarma.

Access to Document

10.1016/j.jtos.2023.05.012

FulltextAccepted author manuscript, 1.19 MBLicence: CC BY-NC-ND

Cite this

Kolko, M., Gazzard, G., Baudouin, C., Beier, S., Brignole-Baudouin, F., Cvenkel, B., Fineide, F., Hedengran, A., Hommer, A., Jespersen, E., Messmer, E. M., Murthy, R., Sullivan, A. G., Tatham, A. J., Utheim, T. P., Vittrup, M., & Sullivan, D. A. (2023). Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. Ocular Surface, 29, 456-468. https://doi.org/10.1016/j.jtos.2023.05.012

Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. / Kolko, Miriam; Gazzard, Gus; Baudouin, Christophe; Beier, Sofie; Brignole-Baudouin, Françoise; Cvenkel, Barbara; Fineide, Fredrik; Hedengran, Anne; Hommer, Anton; Jespersen, Erik; Messmer, Elisabeth M.; Murthy, Rachna; Sullivan, Amy Gallant; Tatham, Andrew J.; Utheim, Tor Paaske; Vittrup, Marijke; Sullivan, David A.

In: Ocular Surface, Vol. 29, 2023, p. 456-468.

Research output: Contribution to journal › Journal article › Research › peer-review

Kolko, M, Gazzard, G, Baudouin, C, Beier, S, Brignole-Baudouin, F, Cvenkel, B, Fineide, F, Hedengran, A, Hommer, A, Jespersen, E, Messmer, EM, Murthy, R, Sullivan, AG, Tatham, AJ, Utheim, TP, Vittrup, M & Sullivan, DA 2023, 'Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment', Ocular Surface, vol. 29, pp. 456-468. https://doi.org/10.1016/j.jtos.2023.05.012

Kolko, Miriam ; Gazzard, Gus ; Baudouin, Christophe ; Beier, Sofie ; Brignole-Baudouin, Françoise ; Cvenkel, Barbara ; Fineide, Fredrik ; Hedengran, Anne ; Hommer, Anton ; Jespersen, Erik ; Messmer, Elisabeth M. ; Murthy, Rachna ; Sullivan, Amy Gallant ; Tatham, Andrew J. ; Utheim, Tor Paaske ; Vittrup, Marijke ; Sullivan, David A. / Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment. In: Ocular Surface. 2023 ; Vol. 29. pp. 456-468.

@article{a8cff162d4394a9da58bc023859d7526,

title = "Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment",

author = "Miriam Kolko and Gus Gazzard and Christophe Baudouin and Sofie Beier and Fran{\c c}oise Brignole-Baudouin and Barbara Cvenkel and Fredrik Fineide and Anne Hedengran and Anton Hommer and Erik Jespersen and Messmer, {Elisabeth M.} and Rachna Murthy and Sullivan, {Amy Gallant} and Tatham, {Andrew J.} and Utheim, {Tor Paaske} and Marijke Vittrup and Sullivan, {David A.}",

note = "Funding Information: Tor Paaske Utheim - Co-owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch + Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, Laboratoire Th{\'e}a. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire Pharmaceuticals. Funding Information: TFOS expresses its appreciation to Julie Karimi (www.jaka.it), Sabrina Zappia (www.citynetonline.it) and Jeremy Chung Bo Chiang (Sydney, Australia) for their outstanding assistance. TFOS also thanks the following industry partners who supported this TFOS Experts' Meeting with unrestricted donations: Santen, Bausch + Lomb, Domp{\'e}, Glaukos, URSAPHARM, Laboratoires Th{\'e}a and VISUfarma.",

year = "2023",

doi = "10.1016/j.jtos.2023.05.012",

language = "English",

volume = "29",

pages = "456--468",

journal = "The Ocular Surface",

issn = "1542-0124",

publisher = "Elsevier",

}

TY - JOUR

T1 - Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

AU - Kolko, Miriam

AU - Gazzard, Gus

AU - Baudouin, Christophe

AU - Beier, Sofie

AU - Brignole-Baudouin, Françoise

AU - Cvenkel, Barbara

AU - Fineide, Fredrik

AU - Hedengran, Anne

AU - Hommer, Anton

AU - Jespersen, Erik

AU - Messmer, Elisabeth M.

AU - Murthy, Rachna

AU - Sullivan, Amy Gallant

AU - Tatham, Andrew J.

AU - Utheim, Tor Paaske

AU - Vittrup, Marijke

AU - Sullivan, David A.

N1 - Funding Information: Tor Paaske Utheim - Co-owner of The Norwegian dry eye clinic and the Clinic of eye health, Oslo, Norway, which delivers talks for and/or receives financial support from: ABIGO, Alcon, Allergan, AMWO, Bausch + Lomb, Bayer, European school for advanced studies in ophthalmology, InnZ Medical, Medilens Nordic, Medistim, Novartis, Santen, Specsavers, Shire Pharmaceuticals, Laboratoire Théa. He has served on the global scientific advisory board for Novartis and Alcon as well as the European advisory board for Shire Pharmaceuticals. Funding Information: TFOS expresses its appreciation to Julie Karimi (www.jaka.it), Sabrina Zappia (www.citynetonline.it) and Jeremy Chung Bo Chiang (Sydney, Australia) for their outstanding assistance. TFOS also thanks the following industry partners who supported this TFOS Experts' Meeting with unrestricted donations: Santen, Bausch + Lomb, Dompé, Glaukos, URSAPHARM, Laboratoires Théa and VISUfarma.

PY - 2023

Y1 - 2023

U2 - 10.1016/j.jtos.2023.05.012

DO - 10.1016/j.jtos.2023.05.012

M3 - Journal article

C2 - 37302545

AN - SCOPUS:85163798187

VL - 29

SP - 456

EP - 468

JO - The Ocular Surface

JF - The Ocular Surface

SN - 1542-0124

ER -